Engaged Capital

Engaged Capital

13F Holdings and Portfolio Analysis

Glenn W. Welling 2016 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.

Engaged Capital Overview

Engaged Capital held 14 stocks in 2016 Q3, with total market value around $0.27B.

Engaged Capital's top five holdings in 2016 Q3: BENCHMARK ELECTRONICS INC(BHE) 22.06%, TIVO CORP COM 17.38%, SUNOPTA INC COMMON STOCK(STKL) 16.52%, MAGNACHIP SEMICONDUCTOR CORP COMMON STOCK(MX) 11.70%, MEDIFAST INC(MED) 10.15%.

Portfolio Value
$0.27B
Current Holdings
14 stocks
New / Increased
5 / 3
Reduced / Exited
2 / 3

Current Holdings

1BENCHMARK ELECTRONICS INCBHE0.0622.06%2.43 -$24.95- $22.720.001.75+$0.01B+9.80%Held
2TIVO CORP COMCUSIP 88870P1060.0517.38%2.45 $19.48- $19.48+2.450.25$0.00B0.00%New
3SUNOPTA INC COMMON STOCKSTKL0.0516.52%6.43 +12119.18%$7.06- $7.04+6.370.50+$0.00B+0.33%Increased
4MAGNACHIP SEMICONDUCTOR CORP COMMON STOCKMX0.0311.70%3.85 -$8.34- $4.910.001.50+$0.01B+69.82%Held
5MEDIFAST INCMED0.0310.15%0.74 -$37.79- $30.900.002.50+$0.01B+22.28%Held
6JAMBA INC COM NEWCUSIP 47023A3090.028.27%2.08 +13.66%$10.92- $13.22+0.252.50-$0.00B-17.38%Increased
7COMSCORE INC COMCUSIP 20564W1050.012.59%0.23 $30.66- $30.66+0.230.25$0.00B0.00%New
8TRIMAS CORP COM NEWTRS0.012.37%0.35 -48.46%$18.61- $25.59-0.332.25-$0.00B-27.28%Reduced
9ISHARES RUSSELL 2000 ETF ETFIWM0.012.29%0.05 +27.93%$124.21- $113.60+0.010.75+$0.00B+9.34%Increased
10BIODELIVERY SCIENCES INTL IN COMCUSIP 09060J1060.011.84%1.88 -$2.70- $3.230.000.75-$0.00B-16.40%Held
11RUBY TUESDAY INC COMCUSIP 7811821000.011.84%2.02 $2.50- $2.50+2.020.25$0.00B0.00%New
12LIBBEY INC COMCUSIP 5298981080.001.56%0.24 -18.17%$17.85- $19.81-0.051.00-$0.00B-9.91%Reduced
13WEB COM GROUP INC COMCUSIP 94733A1040.000.80%0.13 $17.27- $17.27+0.130.25$0.00B0.00%New
14PAREXEL INTL CORPCUSIP 6994621070.000.64%0.03 $69.44- $69.44+0.030.25$0.00B0.00%New
Showing 1-14 of 14

"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.

Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.

Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.

Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.

Exited Holdings

Stocks no longer disclosed in the current 13F portfolio for 2016 Q3.

1OUTERWALL INC COMCUSIP 6900701072.430.75$36.95$42.00+$0.01B+13.68%
2ROVI CORP COMCUSIP 7793761022.452.25$16.74$15.64-$0.00B-6.58%
3AMAG PHARMACEUTICALS INC COMCUSIP 00163U1060.050.75$29.72$23.92-$0.00B-19.53%
Showing 1-3 of 3

Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.

"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.

Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.

Exit return shows estimated dollar return on top and percentage return below.

Portfolio Visuals

Track portfolio value, position weights and Top 10 history.

Market Value Trend ($B)

50 periods

Position Weight

TOP10

Holding Changes ($B)

All-period Top 10

Top 10 Holdings Replay

Animated view